Anti Hair Loss
(Tropical)

TRICHODERM®BlackSeries

Intensive Reactive Serum
Treatment Shampoo

Q&A

Anti Hair Loss
(Act Inside Out)

TRICHODERM®BlackSeries

Intensive Anti-Hair Loss Oral Supplement (Drug-Free)

Q&A

Grey Hair Reverse
(Tropical)

TRICHODERM®BlackSeries

Anti-Grey Hair Treatment Shampoo

Natural Hairyroot Réactif L'Extrait

A Unique Solution Against Hair Loss For Women

A cutting-edge drug-free solution to restoring hair growth factors and
combatting hair loss that’s powered by:

 , is originated from Miliacin which is a rare molecule extracted from whole millet seeds grown in France. It is 100% vegetal, non GMO.

Keranat™ with miliacine biospheres

Growth factors

  • Combats hair loss from the root and rejuvenate hair growth from the bulb
  • Increases collagen thickness around the hair shaft and reinforces hair anchorage in the scalp to allow hair retention and growth
  • Polar Lipids, ceramides for a healthy scalp

Hair Growth Peptides (HGP) 

An egg yolk protein peptide and bioengineering active ingredient from Japan that restores health growth factors

Eggs contain an active ingredient
necessary for hair growth

Protein from egg yolks
Peptide engineering

(Hair Growth peptide)

 Clinically Tested: After 3 months, Hair loss decreased by an average of 50% in users.

A Unique Solution In The Fight Against Hair Loss

  • 6 Years of research-backed insights
  • 5 Ex-vivo studies
  • 2 Clinical studies for proven efficacy
  • 1 Scientific publication
  • 1 Patent in France, Europe and the US
  • 1 Original active mechanism

How does it work?

has been clinically tested for efficacy in hair loss treatments:

– After three months, hair loss decreased by an average of 50% in
 users
– Self-assessment results were coherent with phototrichogram measures and dermatologist evaluations
– Based on all criteria, results from users of were above placebo results:

0%

90% observed a decrease in hair loss

0%

75% noticed an improvement in hair softness and shine

Patented Clinically Studied Ingredients 

 is used under the license from ROBERTET GROUP

Patents: 
EU – No. EP 2 821 952 B1  
USA – No. US 9, 180. 135 B2

Patented Clinically Studied Ingredients

Keranat under the license from ROBERTET GROUP

Patents:
EU – No. EP 2 821 952 B1 USA – No. US 9, 180. 135 B2

A Unique Solution In The Fight Against Hair Loss

6 Years of research-backed insights
5 Ex-vivo studies
2 Clinical studies for proven efficacy
1 Scientific publication
1 Patent in France, Europe and the US
1 Original active mechanism

How Does It Work?

Keranat™ has been clinically tested for efficacy in hair loss treatments:

- After three months, hair loss decreased by an average of 50% in Keranat™ users

- Self-assessment results were coherent with phototrichogram measures and dermatologist evaluations

- Based on all criteria, results from users of Keranat™ were above placebo results:

90% observed a decrease in hair loss
75% noticed an improvement in hair softness and shine

Proven Efficacy

In a 12-week, randomised double-blind, placebo-controlled clinical trial of  , the ingredient has demonstrated to be well-tolerated among users and efficient in reducing hair loss and improving the overall health and quality of hair.

W12/WO

-50%

After three months, hair loss decreased by an average of 50% in   users

A Self-Assessment of 

Hair Density

For the group of KERANAT users, the decrease in hair loss led to an increase in hair density and volume after six weeks.

This effect grew further by the end of the study.

Dermatologist Scoring of 

Hair Beauty & Shine

After 6 weeks, Keranat had already a positive effect on hair beauty and shine.

This effect grew further by the end of the study. 

A Self-Assessment of 

Hair volume

After 6 weeks, KERANAT is shown to have a positive effect on the hair’s volume.

This effect grew further by the end of the study.

#Clinical Studies:
Clinical evaluation of Miliacin on hair cycle and hair beauty – Double blind study, randomised, versus placebo, performed under dermatological control Evaluation of a food supplement KERANAT efficacy on hair loss by the phototrichogram method, evaluation of tolerance and acceptability after 6 and 12 weeks – Double blind study, randomised, versus placebo, performed under dermatological control

 

Pull test results:
The results of the pull test of the hair carried out in response to this are shown in the figure.

Pull test was done by having a dermatologist pull a certain number of hairs (about ten hairs) with the same force and judge the result as "positive" when two or more hairs were pulled out. In the Keranat group, "positive" subjects who were present at 40% at the start of the study, became zero at the end of the study, and the attachment strengthening of the hair was confirmed.

堀江義明 Yoshiaki Horie

-

Medical Director 醫學總監
(Ebisu Beauty Clinic 惠比壽美容クリニック)